A case of malignant cerebral infarction associated with COVID-19 infection

References

• Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268–70.
   PubMed Web of Science ®Google Scholar
• Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77(6):1-9.
   Web of Science ®Google Scholar
• Zhai P, Ding Y, Li Y. The impact of COVID-19 on ischemic stroke.Version 2. Diagn Pathol. 2020;15(1):78.
   Google Scholar
• Zhou L, Zhang M, Wang J, Gao J. Sars-Cov-2: underestimated damage to nervous system. Travel Med Infect Dis 2020;Mar 24:101642.
   Web of Science ®Google Scholar
• Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020;19:383–4.
   PubMed Web of Science ®Google Scholar
• Li Y, Bai W, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol 2020;92:552–5.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis 2005;41:1089–96.
   PubMed Web of Science ®Google Scholar
• Desforges M, Le Coupanec A, Dubeau P, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 2019;12:14.
   PubMed Web of Science ®Google Scholar
• Baig A, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11:995–8.
   PubMed Web of Science ®Google Scholar
• Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J Am Heart Assoc 2020;9:e016219.
   PubMed Web of Science ®Google Scholar
• Xiang P, Xu XM, Gao LL, Wang HZ, Xiong HF, Li RH. 2020. First case of 2019 novel coronavirus disease with Encephalitis. ChinaXiv, 202003, p.00015.
   Google Scholar
• Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020;94:55–8.
   PubMed Web of Science ®Google Scholar
• Filatov A, Sharma P, Hindi F, Espinosa P. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 2020;12(3):e7352.
   Web of Science ®Google Scholar
• Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020;31:201187.
   Web of Science ®Google Scholar
• Oxley T, Mocco J, Majidi S, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020;382:e60.
   PubMed Web of Science ®Google Scholar
• Ye M, Ren Y, Lv T. Encephalitis as a clinical manifestation of COVID-19. Brain Behav Immunity 2020;S0889-1591(20)30465-7.
   Web of Science ®Google Scholar
• Hwang C. Olfactory neuropathy in severe acute respiratory syndrome: report of a case. Acta Neurol Taiwan 2006;15:26–8.
   PubMedGoogle Scholar
• Nagel MA, Mahalingam R, Cohrs RJ, Gilden D. Virus vasculopathy and stroke: an under-recognized cause and treatment target. Infect Disord Drug Targets 2010;10:105–11.
   PubMedGoogle Scholar
• Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol 2020;99(6):1205–1208.
   PubMed Web of Science ®Google Scholar
• Li H, Liu L, Zhang D, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet 2020;395:1517–20.
   PubMed Web of Science ®Google Scholar
• Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immunity 2020;87:18–22.
   PubMed Web of Science ®Google Scholar
• Spiteri G, Fielding J, Diercke M, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Eurosurveillance 2020;25:2000178.
   Web of Science ®Google Scholar
• Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci 2020;16:1678–85.
   PubMed Web of Science ®Google Scholar
• Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020;220:1–13.
   PubMed Web of Science ®Google Scholar
• Inciardi R, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;10.1001/jamacardio.2020.1096.
   PubMed Web of Science ®Google Scholar